نتائج البحث

Bemcentinib and pembrolizumab in patients with relapsed mesothelioma: MIST3, a phase IIa trial with cellular and molecular correlates of efficacy.

• Authors : Krebs, Matthew; Branson, Amy; Barber, Shaun

• Source: Krebs , M , Branson , A , Barber , S , Poile , C , King , A , Greystoke , A , Moody , S , Nolan , L , Scotland , M , Darlison , L , Bajaj , A , Morgan , B , Brookes , C , Wells-Jordan , P , Richards ,

تفاصيل العنوان